Drug Mechanisms
Drug Mechanisms - Related Videos
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
0 Views •
Cited by 8 •
2014
Approaches for testing the effects of antipsychotic drugs (APDs) in Caenorhabditis elegans are demonstrated. Assays are described for testing drug effects on development and viability and on pharyngeal pumping rate. These methods are also applicable for pharmacogenetic experiments with drug classes other than APDs.
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
0 Views •
Cited by 14 •
2011
Basophil activation test is a potent tool for the detection of IgE-dependent allergies in vitro. Here, an optimized protocol for basophil activation test is used to investigate drug hypersensitivity. A method for the efficient production of covalent drug-protein conjugates and their physicochemical characterization is described.
01:16
Protein-Drug Binding: Mechanism and Kinetics
0 Views •
2025
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood. Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
01:23
Drug Absorption Mechanism: Passive Membrane Transport
0 Views •
2023
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either weak...
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
0 Views •
Cited by 2 •
2015
Drug resistance to targeted therapeutics is widespread and the need to identify mechanisms of resistance--prior to or following clinical onset--is critical for guiding alternative clinical management strategies. Here, we present a protocol to couple derivation of drug-resistant lines in vitro with sequencing to expedite discovery of these mechanisms.
FAQs
These factors determine which molecular targets are affected, how strongly they are influenced, and where the drug acts in the body. A dose can change the magnitude of downstream signaling, while target selectivity may separate desired effects from unwanted ones. Tissue distribution further determines which physiological functions experience the drug’s action, helping explain differences in efficacy and safety.
Receptors, enzymes, ion channels, and transporters regulate cellular function through different processes, so altering each target can produce distinct downstream effects. Receptor binding may change signaling, enzyme inhibition can modify metabolism, ion-channel activity can alter cellular electrical behavior, and transporter changes can affect movement of substances. Identifying the target class helps connect molecular action with physiological outcomes.
A single drug action can influence more than one physiological process, particularly when target selectivity is limited or the target is present in multiple tissues. The resulting downstream signaling, metabolic changes, or altered transport may generate the intended therapeutic response while also disturbing other functions. Mechanistic analysis helps distinguish these linked effects and clarify the basis of toxicity.
Drug interactions can be interpreted by examining how medicines alter targets, signaling, metabolism, or transporters in overlapping ways. If one drug changes a process that another drug also depends on or affects, their combined actions may modify efficacy or unwanted effects. Mechanistic knowledge therefore provides a framework for anticipating interaction-related changes rather than evaluating each medicine in isolation.
A mechanism-focused evaluation traces the relationship from molecular action through cellular consequences to physiological and clinical effects. Researchers consider the relevant target, downstream signaling or metabolic change, dose, selectivity, and tissue distribution, then assess how these factors relate to efficacy and safety. This approach converts molecular observations into information useful for interpreting treatment responses.
Mechanistic knowledge supports several stages of pharmacology research, including discovering and optimizing treatments, selecting doses, and assessing safety. It also helps researchers investigate resistance, toxicity, and possible new therapeutic uses. By explaining how molecular actions produce clinical outcomes, this framework can guide decisions about whether a treatment’s effects are sufficiently selective, predictable, and useful.